A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Clinical trial NCT01373164 · COMPLETED
Trial details
- NCT number
- NCT01373164
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2015-11-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.